Loading...
OTCM
CTGL
Market cap104kUSD
Mar 26, Last price  
0.00USD
Name

Citrine Global Corp

Chart & Performance

D1W1MN
No data to show
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
108.66%
Rev. gr., 5y
-15.66%
Revenues
-24k
L-53.85%
092,9085,8165,8005,8245,84800251,417149,08511,372-52,000-24,000
Net income
-3m
L-18.60%
-14,302-70,599-349,145-1,445,529-4,365,589-1,533,589-1,853,722-2,858,390-2,157,074-1,912,522-8,289,401-4,059,000-3,304,000
CFO
-567k
L-2.58%
-8,1186,866-175,755-352,942-1,806,298-1,029,288-1,290,231-1,470,395-2,386,436-1,225,577-696,033-582,000-567,000

Profile

Citrine Global Corp. operates as a plant-based wellness and pharma solutions company. It focuses on developing plant-based products to enhance quality of life, and complementary solutions for balancing side effects caused by using medicines, cannabis, treatments, or an unbalanced lifestyle. The company was formerly known as TechCare Corp. and changed its name to Citrine Global Corp. in August 2020. Citrine Global Corp. was incorporated in 2010 and is headquartered in Herzliya, Israel.
IPO date
Jun 01, 2010
Employees
18
Domiciled in
IL
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
(24)
-53.85%
Cost of revenue
122
Unusual Expense (Income)
NOPBT
(146)
NOPBT Margin
608.33%
Operating Taxes
659
Tax Rate
NOPAT
(805)
Net income
(3,304)
-18.60%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
82
Long-term debt
1,975
Deferred revenue
Other long-term liabilities
Net debt
1,086
Cash flow
Cash from operating activities
(567)
CAPEX
(4)
Cash from investing activities
11
Cash from financing activities
360
FCF
1,293
Balance
Cash
77
Long term investments
894
Excess cash
972
Stockholders' equity
(26,193)
Invested Capital
25,779
ROIC
ROCE
35.27%
EV
Common stock shares outstanding
942,963
Price
0.04
35.71%
Market cap
35,833
35.77%
EV
36,919
EBITDA
(144)
EV/EBITDA
Interest
635
Interest/NOPBT